Skip to main content
. Author manuscript; available in PMC: 2019 Nov 1.
Published in final edited form as: Trends Cancer. 2018 Sep 28;4(11):741–754. doi: 10.1016/j.trecan.2018.09.004

Figure 3. Antibody-based Therapies Targeting Glypicans in Cancer.

Figure 3.

ADC: antibody- drug-conjugate; CAR: chimeric antigen receptor; CTL: cytotoxic T lymphocyte; TCR: T- cell receptor; MHC: major histocompatibility complex; APC: antigen-presenting cell; GPC: glypican; ER: endoplasmic reticulum (adapted with permission from [96]).